{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=44&state=Ohio", "query": { "state": "Ohio", "city": "Cleveland", "page": 44 }, "page_size": 10 }, "pagination": { "page": 44, "page_size": 10, "total_count": 11338, "total_pages": 1134, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=45&state=Ohio&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Cleveland&page=43&state=Ohio&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T13:58:55.002Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04226547", "title": "Amplatzer Amulet LAAO vs. NOAC", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atrial Fibrillation", "Stroke", "Bleeding" ], "interventions": [ { "name": "Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)", "type": "DEVICE" }, { "name": "Non-Vitamin K Oral Antagonists", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2650, "start_date": "2020-07-07", "completion_date": "2031-04", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 79, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04226547" }, { "nct_id": "NCT01287247", "title": "Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Dystonia", "Blepharospasm" ], "interventions": [ { "name": "Xeomin®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 688, "start_date": "2011-02", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2015-04-10", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 70, "location_summary": "Cullman, Alabama • Scottsdale, Arizona • Tucson, Arizona + 60 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287247" }, { "nct_id": "NCT07649148", "title": "Dietary Tracking in Heart Failure", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure", "NYHA Class II Heart Failure", "NYHA Class III Heart Failure" ], "interventions": [ { "name": "Limiting Ultraprocessed Food (UPF) in Diet", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-12", "completion_date": "2040-12", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07649148" }, { "nct_id": "NCT03494660", "title": "SCP Hip Outcomes Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Subchondral Cysts", "Subchondral Bone Edema", "Bone Marrow Edema", "Insufficiency Fractures", "Avascular Necrosis of Hip", "Femoroacetabular Impingement", "Dysplasia; Hip" ], "interventions": [ { "name": "Subchondroplasty Procedure with AccuFill", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2018-03-27", "completion_date": "2025-01-13", "has_results": true, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 6, "location_summary": "Rancho Mirage, California • Gulf Breeze, Florida • Rockford, Illinois + 3 more", "locations": [ { "city": "Rancho Mirage", "state": "California" }, { "city": "Gulf Breeze", "state": "Florida" }, { "city": "Rockford", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03494660" }, { "nct_id": "NCT04096560", "title": "A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy Type 1 (NT1)", "Narcolepsy Type 2 (NT2)" ], "interventions": [ { "name": "TAK-994", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 97, "start_date": "2020-05-27", "completion_date": "2021-11-05", "has_results": true, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 36, "location_summary": "Alabaster, Alabama • Phoenix, Arizona • Bellflower, California + 31 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bellflower", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04096560" }, { "nct_id": "NCT06153420", "title": "Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Irritable Bowel Syndrome With Diarrhea" ], "interventions": [ { "name": "CIN-103", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CinPhloro Pharma, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2023-12-28", "completion_date": "2025-07-28", "has_results": false, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 53, "location_summary": "Dothan, Alabama • Huntsville, Alabama • Phoenix, Arizona + 45 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06153420" }, { "nct_id": "NCT00003123", "title": "Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myelodysplastic Syndromes" ], "interventions": [ { "name": "amifostine trihydrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Providence Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": null, "sex": "ALL", "summary": "17 Years and older" }, "enrollment_count": 36, "start_date": "1997-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 7, "location_summary": "Clinton Township, Michigan • Detroit, Michigan • Garden City, Michigan + 3 more", "locations": [ { "city": "Clinton Township", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Garden City", "state": "Michigan" }, { "city": "Marquette", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003123" }, { "nct_id": "NCT01597440", "title": "Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Propionic Acidemia", "Methylmalonic Acidemia" ], "interventions": [ { "name": "N-carbamylglutamate", "type": "DRUG" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mendel Tuchman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Hour", "maximum_age": "4 Weeks", "sex": "ALL", "summary": "1 Hour to 4 Weeks" }, "enrollment_count": 1, "start_date": "2012-09", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2017-04-26", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 7, "location_summary": "Los Angeles, California • Palo Alto, California • Aurora, Colorado + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01597440" }, { "nct_id": "NCT00014989", "title": "Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Palsy", "Intraventricular Hemorrhage", "Periventricular Leukomalacia", "Pulmonary Edema", "Abruptio Placentae" ], "interventions": [ { "name": "magnesium sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The George Washington University Biostatistics Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 2136, "start_date": "1997-12", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2019-07-12", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Miami, Florida • Chicago, Illinois + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00014989" }, { "nct_id": "NCT04133168", "title": "Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Paroxysmal Atrial Fibrillation" ], "interventions": [ { "name": "Boston Scientific Cardiac Cryoablation System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 458, "start_date": "2020-06-24", "completion_date": "2023-08-17", "has_results": true, "last_update_posted_date": "2025-04-03", "last_synced_at": "2026-11-15T13:58:55.002Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04133168" } ] }